✦ LIBER ✦

Clinical relevance of Achromobacter xylosoxidans from patients with cystic fibrosis

✍ Scribed by P. Dentini; K. Fiolo; J.D. Ribeiro; A.F. Ribeiro; L.M. Hollanda; M. Brocchi; C.E. Levy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achromobacter xylosoxidans in cystic fib

✍ Frans De Baets; Petra Schelstraete; Sabine Van Daele; Filomeen Haerynck; Mario V 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 90 KB

128 Achromobacter (A.) xylosoxidans in c

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Microbiological characteristics of Achro

✍ C.E. Levy; C.Z. Esteves; P. Dentini; L.C. Bonadia; C.S. Bertuzzo; A.F. Ribeiro; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Chronic infection with Achromobacter xyl

✍ Christine Rønne Hansen; Tacjana Pressler; Niels Høiby; Magdalena Gormsen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 264 KB

117 Achromobacter xylosoxidans character

✍ Trancassini, M.; Citerà, N.; Tuccio, V.; Magni, A.; Iebba, V.; De Biase, R.V.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Epidemiology and resistance of Achromoba

✍ Amoureux, Lucie; Bador, Julien; Siebor, Eliane; Taillefumier, Nathalie; Fanton, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 143 KB